Swiss Biotech Day 2023
Swiss Biotech Day 2023
Congress Center Basel, Switzerland
The Swiss Biotech Day has become one of the leading biotechnology conferences in Europe and a fixed date in the community’s calendar. In 2023, the Swiss Biotech Day will again offer high-level experts from the life sciences industry the space and the time to network, discuss and discover trends in R&D, manufacturing, data management, artificial intelligence and innovative financing.
Javits Center, New York City, the United States
Interphex, the largest and the world’s most trusted life science exhibition for chemical and biopharmaceutical sectors, is held once a year in spring in New York City, the United States. Exhibitors meet with decision-making buyers from global leading pharmaceutical companies at the show. In addition to representatives of US pharmaceutical companies, industry professionals from South America, Europe and Asia come here every year to find cutting-edge technologies, quality products and services in the pharmaceutical industry.
About Pharmadule Morimatsu AB
As a well-known specialized provider of modular pharmaceutical facilities and solutions, Pharmadule has successfully delivered more than 80 projects with its modular manufacturing facilities for the pharmaceutical and biopharmaceutical industries since 1986, completing more than 300 engineering and validation solutions. With extensive experience in international project delivery and proper understanding of regulatory requirements in different regions, Pharmadule continues to provide a range of engineering and solutions to pharmaceutical and biopharmaceutical clients worldwide.
After becoming a member of Morimatsu Group in 2011, Pharmadule Morimatsu AB perfectly integrates modular facilities with process thanks to the strong combination, allowing the company to unify the needs of process, operation, maintenance, safety, energy saving and other aspects. This is more conductive to optimizing the overall management of facility construction and process flow, and is more favorable to providing customers with higher-quality, faster turnkey solutions. Globally, many leading multinational companies in the pharmaceutical industry such as Eli Lilly, Merck, Baxter, GSK, Genentech, AZ and Lonza have chosen Pharmadule Morimatsu AB to provide faster and more effective treatments for patients worldwide.
Pharmadule Morimatsu AB will present new project cases and solutions at the exhibition. The company will have an exchange of views with industry professionals on new developments in digital and intelligent turnkey plant solutions, modular facilities, process systems, bioreactors and other products. Look forward to seeing you there!
About Morimatsu Life Science
Morimatsu Life Science is the sanitary business segment of Morimatsu International Holding Co., Ltd. (Morimatsu International, stock code: 2155.HK), covering industries such as pharmaceuticals, biopharmaceuticals, FMCG, cosmetic and electronic chemicals, and mainly includes Shanghai Morimatsu Pharmaceutical Equipment Engineering Co., Ltd., Morimatsu (Suzhou) Life Technology Co., Ltd., Shanghai Morimatsu Biotechnology Co., Ltd., Pharmadule Morimatsu AB (Sweden) and other companies and their affiliates, focusing on the R&D, manufacturing and sales of products in related fields.
Morimatsu, founded in Japan and taken root in China, has developed into a multi-national company that embraces globalization, masters core technology, and gains rich experience from project implementation in diverse fields including core equipment, process systems, and engineering solutions. Starting from its advanced manufacturing base in China, Morimatsu International has opened subsidiaries or plants in Sweden, the United States, India, Italy, Malaysia and Singapore, and has delivered different forms of products and services to more than 40 countries and regions so far, by virtue of its global footprint of efficient and professional team.
The information in this press release may include some forward-looking statements. Such statements are essentially susceptible to considerable risks and uncertainties. The use of “predicted”, “believed”, “forecast”, “planned” and/or other similar words/phrases in all statements related to our company is to indicate that the statements are forward-looking ones. Our company undertakes no obligation to constantly revise such predicted statements.
Forward-looking statements are based on our company management’s current perspectives, assumptions, expectations, estimations, predictions and understanding of future affairs at the time of the making of such statements. Such statements are not guaranties of future development and are susceptible to the impact of risks, uncertainties and other factors; some are beyond the control of our company and unpredictable. Subject to the influence of future changes and development in our business, competition environment, political, economic, legal and social conditions, the actual outcomes may differ significantly from the information contained in the forward-looking statements.